{
    "Trade/Device Name(s)": [
        "Accurate Multi Panel Drug Urine Test Cup"
    ],
    "Submitter Information": "Healstone Biotech Inc.",
    "510(k) Number": "K191841",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182701"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NGL",
        "PTH",
        "NFV",
        "NFY",
        "PTG",
        "QBF",
        "NGG",
        "QAW",
        "NGM",
        "NFW"
    ],
    "Summary Letter Date": "July 5, 2019",
    "Summary Letter Received Date": "July 9, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine test system",
        "Methadone test system",
        "Methamphetamine test system",
        "Opiate test system",
        "Propoxyphene test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methamphetamine",
        "Methylenedioxymethamphetamine (MDMA)",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Nortriptyline",
        "Marijuana (THC)"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Test cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Accurate Multi Panel Drug Urine Test Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Antigen-antibody reaction",
        "Qualitative screening"
    ],
    "Submission Type(s)": [
        "Test cup",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Accurate Multi Panel Drug Urine Test Cup for qualitative and simultaneous detection of multiple drugs of abuse in human urine",
    "Indications for Use Summary": "Qualitative and simultaneous detection of amphetamine, buprenorphine, secobarbital, oxazepam, cocaine, EDDP, methamphetamine, MDMA, morphine, methadone, oxycodone, phencyclidine, propoxyphene, nortriptyline, and marijuana in human urine; for in vitro diagnostic use only",
    "fda_folder": "Toxicology"
}